This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaneda, A. Articles by Ushijima, T. Search for Related Content PubMed PubMed Citation Articles by Kaneda, A. Articles by Ushijima, T.

Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers

¹ Carcinogenesis Division, National Cancer Center Research Institute, Tokyo; ² Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo; and ³ Division of Oncological Pathology, Aichi Cancer Center Research Institute, Aichi, Japan

Lysyl oxidase (LOX) and HRAS-like suppressor (HRASLS) are silenced in human gastric cancers and are reported to have growth-suppressive activities in ras-transformed mouse/rat fibroblasts. Here, we analyzed whether or not LOX and HRASLS are tumor suppressor genes in human gastric cancers. Loss of heterozygosity and promoter methylation of LOX were detected in 33% (9 of 27) and 27% (26 of 96) of gastric cancers, respectively. Biallelic methylation and loss of heterozygosity with promoter methylation were also demonstrated in gastric cancers. Silencing of LOX was also observed in colon, lung, and ovarian cancer cell lines. As for mutations, only one possible somatic mutation was found by analysis of 96 gastric cancer samples and 58 gastric and other cancer cell lines. When LOX was introduced into a gastric cancer cell line, MKN28, in which LOX and HRASLS were silenced, it reduced the number of anchorage-dependent colonies to 57 to 61%, and the number of anchorage-independent colonies to 11 to 23%. Sizes of tumors formed in nude mice were reduced to 19 to 26%. Growth suppression in soft agar assay was also observed in another gastric cancer cell line, KATOIII. On the other hand, neither loss of heterozygosity nor a somatic mutation was detected in HRASLS, and its introduction into MKN28 did not suppress the growth in vitro or in vivo. These data showed that LOX is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in gastric cancers, and possibly also in other cancers.

This article has been cited by other articles:

				H. Enderling, N. R. Alexander, E. S. Clark, K. M. Branch, L. Estrada, C. Crooke, J. Jourquin, N. Lobdell, M. H. Zaman, S. A. Guelcher, et al. Dependence of Invadopodia Function on Collagen Fiber Spacing and Cross-Linking: Computational Modeling and Experimental Evidence Biophys. J., September 1, 2008; 95(5): 2203 - 2218. [Abstract] [Full Text] [PDF]

				R. Napieralski, K. Ott, M. Kremer, K. Becker, A.-L. Boulesteix, F. Lordick, J. R. Siewert, H. Hofler, and G. Keller Methylation of Tumor-Related Genes in Neoadjuvant-Treated Gastric Cancer: Relation to Therapy Response and Clinicopathologic and Molecular Features Clin. Cancer Res., September 1, 2007; 13(17): 5095 - 5102. [Abstract] [Full Text] [PDF]

				T.-M. Shieh, S.-C. Lin, C.-J. Liu, S.-S. Chang, T.-H. Ku, and K.-W. Chang Association of Expression Aberrances and Genetic Polymorphisms of Lysyl Oxidase with Areca-Associated Oral Tumorigenesis Clin. Cancer Res., August 1, 2007; 13(15): 4378 - 4385. [Abstract] [Full Text] [PDF]

				G. Wu, Z. Guo, X. Chang, M. S. Kim, J. K. Nagpal, J. Liu, J. M. Maki, K. I. Kivirikko, S. P. Ethier, B. Trink, et al. LOXL1 and LOXL4 Are Epigenetically Silenced and Can Inhibit Ras/Extracellular Signal-Regulated Kinase Signaling Pathway in Human Bladder Cancer Cancer Res., May 1, 2007; 67(9): 4123 - 4129. [Abstract] [Full Text] [PDF]

				C. Min, K. H. Kirsch, Y. Zhao, S. Jeay, A. H. Palamakumbura, P. C. Trackman, and G. E. Sonenshein The Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Reverses the Invasive Phenotype of Her-2/neu-Driven Breast Cancer Cancer Res., February 1, 2007; 67(3): 1105 - 1112. [Abstract] [Full Text] [PDF]

				J. T. Erler and A. J. Giaccia Lysyl Oxidase Mediates Hypoxic Control of Metastasis Cancer Res., November 1, 2006; 66(21): 10238 - 10241. [Abstract] [Full Text] [PDF]

				M.-S. Chang, H. Uozaki, J.-M. Chong, T. Ushiku, K. Sakuma, S. Ishikawa, R. Hino, R. R. Barua, Y. Iwasaki, K. Arai, et al. CpG Island M;ethylation Status in Gastric Carcinoma with and without Infection of Epstein-Barr Virus. Clin. Cancer Res., May 15, 2006; 12(10): 2995 - 3002. [Abstract] [Full Text] [PDF]

				C. Bouez, C. Reynaud, E. Noblesse, A. Thepot, C. Gleyzal, J. Kanitakis, E. Perrier, O. Damour, and P. Sommer The Lysyl Oxidase LOX Is Absent in Basal and Squamous Cell Carcinomas and Its Knockdown Induces an Invading Phenotype in a Skin Equivalent Model Clin. Cancer Res., March 1, 2006; 12(5): 1463 - 1469. [Abstract] [Full Text] [PDF]

				W. Chu, Z. Ghahramani, F. Falciani, and D. L. Wild Biomarker discovery in microarray gene expression data with Gaussian processes Bioinformatics, August 15, 2005; 21(16): 3385 - 3393. [Abstract] [Full Text] [PDF]